Moody, Kate A.
Iofel, Samuel S.
Clements, Matthew B.
Article History
Accepted: 16 October 2024
First Online: 11 December 2024
Declarations
:
: Matthew B. Clements was the PI for Lahey for the SunRISE3 trial which was sponsored by Janssen Pharmaceuticals. He received no financial incentives related to participation in the study and has no other relevant ties to the sponsor. Additionally the study has now been closed to enrollment in the US and therefore is not currently underway at our site.
: All reported studies/experiments with human subjects performed by the authors were performed in accordance with all applicable ethical standards including the Helsinki Declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines.